Home › Funds › Two Sigma Investments › VRCA
Two Sigma Investments position in VRCA
VERRICA PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)40.83K sh
Reported value held$249.85K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 54.27K | $104.00K | New |
| Q3 2022 | 48.89K | $143.00K | Reduce |
| Q4 2022 | 50.82K | $139.75K | Add |
| Q1 2023 | 47.09K | $306.11K | Reduce |
| Q2 2023 | 69.36K | $400.20K | Add |
| Q3 2023 | 64.56K | $250.81K | Reduce |
| Q1 2024 | 25.09K | $148.53K | New |
| Q2 2024 | 42.79K | $311.97K | Add |
| Q3 2024 | 115.28K | $167.16K | Add |
| Q4 2024 | 128.44K | $89.91K | Add |
| Q1 2025 | 88.67K | $39.21K | Reduce |
| Q1 2025 | 88.67K | $39.21K | Reduce |
| Q2 2025 | 87.29K | $46.27K | Reduce |
| Q2 2025 | 87.29K | $46.27K | Reduce |
| Q4 2025 | 118.22K | $982.39K | New |
| Q1 2026 | 50.66K | $268.00K | Reduce |
| Q2 2026 | 40.83K | $249.85K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VRCA
- Vanguard Group 138.19K sh · $1.15M · Q4 2025
- Geode Capital Management 138.16K sh · $845.66K · Q2 2026
- BlackRock Inc 74.34K sh · $454.99K · Q2 2026
- Northern Trust Corp 27.00K sh · $165.22K · Q2 2026
- Renaissance Technologies 21.77K sh · $133.23K · Q2 2026
- UBS Group AG 6.07K sh · $37.16K · Q2 2026
- Morgan Stanley 3.20K sh · $19.59K · Q2 2026
- PNC Financial Services 102 sh · $624 · Q2 2026
- JPMorgan Chase & Co 47 sh · $306 · Q2 2026